Literature DB >> 2888027

Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus.

R Andrade, R A Nicoll.   

Abstract

The effects of buspirone on hippocampal pyramidal cells of the CA1 region were examined by means of intracellular recordings in in vitro hippocampal brain slices. Bath administration of buspirone elicited a long lasting hyperpolarization which was mediated by an increase in potassium conductance and resembled the hyperpolarizing component of the response to 5-HT (5-hydroxytryptamine). Buspirone, however, failed to mimic the depolarizing action of 5-HT or to reduce the calcium-activated after hyperpolarization. Quantitative comparisons of the hyperpolarizing responses of 5-HT and buspirone revealed that the maximal hyperpolarization induced by buspirone was significantly smaller than that induced by 5-HT. Since the buspirone induced hyperpolarization was also accompanied by a surmountable antagonism of 5-HT responses, these results indicate that buspirone behaves as a partial agonist at a subpopulation of 5-HT receptors in the CA1 region of the hippocampus. Administration of the buspirone congeners gepirone and isapirone also elicited a hyperpolarization and reduced 5-HT responses, although they lack antidopaminergic activity, indicating that the effects observed with buspirone are unlikely to be mediated through dopamine receptors. These results indicated that novel anxiolytics can discriminate between functional 5-HT receptors. In conjunction with previous biochemical and electrophysiological studies, the present results suggest that their administration might alter the balance of serotonergic actions on postsynaptic neurons.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888027     DOI: 10.1007/bf00177743

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  The pharmacological classification of practolol and chloropractolol.

Authors:  T P Kenakin; J W Black
Journal:  Mol Pharmacol       Date:  1978-07       Impact factor: 4.436

2.  Buspirone: action on serotonin receptors in calf hippocampus.

Authors:  T Glaser; J Traber
Journal:  Eur J Pharmacol       Date:  1983-03-18       Impact factor: 4.432

3.  Computer-assisted autoradiographic localization of subtypes of serotonin1 receptors in rat brain.

Authors:  P P Deshmukh; H I Yamamura; L Woods; D L Nelson
Journal:  Brain Res       Date:  1983-12-12       Impact factor: 3.252

4.  A simple chamber for recording from submerged brain slices.

Authors:  R A Nicoll; B E Alger
Journal:  J Neurosci Methods       Date:  1981-08       Impact factor: 2.390

5.  Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

Authors:  J A Engel; S Hjorth; K Svensson; A Carlsson; S Liljequist
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

6.  Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites.

Authors:  T Glaser; J Traber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

7.  Pharmacology and neurochemistry of buspirone.

Authors:  L A Riblet; D P Taylor; M S Eison; H C Stanton
Journal:  J Clin Psychiatry       Date:  1982-12       Impact factor: 4.384

8.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists.

Authors:  J S Sprouse; G K Aghajanian
Journal:  Synapse       Date:  1987       Impact factor: 2.562

9.  Buspirone: chemical profile of a new class of anxioselective agents.

Authors:  D L Temple; J P Yevich; J S New
Journal:  J Clin Psychiatry       Date:  1982-12       Impact factor: 4.384

10.  Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.

Authors:  C P VanderMaelen; G K Matheson; R C Wilderman; L A Patterson
Journal:  Eur J Pharmacol       Date:  1986-09-23       Impact factor: 4.432

View more
  25 in total

1.  Regulation of 5-HT(1A) receptor-stimulated [35S]-GtpgammaS binding as measured by quantitative autoradiography following chronic agonist administration.

Authors:  J Hensler; H Durgam
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  The 5-HT1A receptor: an overview of recent advances.

Authors:  S el Mestikawy; A Fargin; J R Raymond; H Gozlan; M Hnatowich
Journal:  Neurochem Res       Date:  1991-01       Impact factor: 3.996

3.  Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors).

Authors:  M Riad; K C Watkins; E Doucet; M Hamon; L Descarries
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

4.  Neuroendocrine effects of ipsapirone on the hypothalamic-pituitary adrenal axis: CRF, ACTH and cortisol in healthy volunteers.

Authors:  M Beneke; W Wingender; R Horstmann; I Konrad-Dalhoff; H Weber; J Kuhlmann; B H Schmidt
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers.

Authors:  Vassilis Koudas; Alexandra Nikolaou; Eugenia Hourdaki; Stella G Giakoumaki; Panos Roussos; Panos Bitsios
Journal:  Psychopharmacology (Berl)       Date:  2009-03-14       Impact factor: 4.530

6.  Partial agonistic activity of R- and S-enantiomers of 8-OH-DPAT at 5-HT1A receptors.

Authors:  V Hadrava; P Blier; C de Montigny
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

7.  Unitary properties of potassium channels activated by 5-HT in acutely isolated rat dorsal raphe neurones.

Authors:  N J Penington; J S Kelly; A P Fox
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

8.  8-Hydroxy-2-(di-n-propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A receptors.

Authors:  M Carli; R Samanin
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

9.  Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain.

Authors:  R Oishi; Y Itoh; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

10.  Use-dependent effects of acute and chronic treatment with imipramine and buspirone on excitatory synaptic transmission in the rat hippocampus in vivo.

Authors:  J J O'Connor; M J Rowan; R Anwyl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.